ELMDELMDHealthcare · Medical Devices

ELMD Stock Forecast: Electromed, Inc. Price Predictions for 2026-2027

Last close, 20 Nov 2026
$23
−1.20% on the day

The median 12-month analyst price target for Electromed, Inc. is $49. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 89 of 100 as at 21 Nov 2026 — inside the top quartile.

Market cap
$190.1M
Ticker Nerd rank
89/ 100
Median analyst target
$49
Analysts covering
2
Revenue$19.4M+11.6% y/y
Operating income$3.8M
Net income$3.4M
Free cash flow$2.8M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−5.5%
1M
−16.3%
YTD
−21.1%
1Y
−8.4%
From 52W high
−50.4%
From 52W low
0.0%
$23
$46
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

One number for the whole business

Consensus tells you what everyone already believes. The model scores Electromed, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Nov 2026
89/ 100

Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Quality
99
Value
93
Growth
85
Issuance
79
Volatility
78
Momentum
56
Revisions
44
Accruals
25

Quality (99): The business earns solid, repeatable profits on what it owns.

Accruals (25): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

ELMD stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ELMD, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$20$25$30$35$40$45$50$55Jan 26Apr 26Jul 26Oct 26ELMDHigh $50Median $49Low $47

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says2 analysts
2
Buy
0
Hold
0
Sell
$47
Low
$49
Median
$50
High
Recent analyst actionsNewest first
DateFirmActionRatingTarget
26 Aug 2026Lake StreetMaintainsBuy—
13 May 2026B. Riley SecuritiesMaintainsBuy—
12 Feb 2026Freedom BrokerMaintainsBuy—
19 Nov 2025Freedom BrokerMaintainsBuy—
13 Nov 2025Roth CapitalReiteratesBuy—
27 Aug 2025Lake StreetAssumesBuy$36
27 Aug 2025Roth CapitalMaintainsBuy—
22 July 2025Roth CapitalInitiatesBuy—
20 Feb 2025B. Riley SecuritiesInitiatesBuy—
11 May 2023EF HuttonReiteratesBuy—
16 Feb 2023EF HuttonMaintainsBuy—
15 Feb 2023Lake StreetMaintainsBuy—
28 Dec 2022Lake StreetAssumesBuy$20
6 Sept 2022EF HuttonInitiatesBuy—
5 Aug 2022Lake StreetInitiatesBuy—
24 Nov 2020Northland Capital MarketsInitiatesOutperform—
18 Oct 2019Dougherty & Co.InitiatesBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for ELMD.

Market Radar

This page is one stock. Monday covers all of them.

ELMD appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

ELMD vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 20 Nov 2026, Electromed, Inc. returned −8.4% against +6.9% for the S&P 500, dividends included.

ELMD vs S&P 500, last 12 monthsTotal return, rebased to 100
80100120140160180Jan 26Apr 26Jul 26Oct 26ELMDS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

ELMD analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
EPS revision, 90 days
−0.3%
Analysts raising
1
Analysts cutting
1
Fundamentals

Financials

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
16.7×

Cheaper than 52% of US stocks

Price / sales
2.5×

Cheaper than 42% of US stocks

Price / book
3.6×

Cheaper than 26% of US stocks

EV / EBITDA
11.2×

Cheaper than 51% of US stocks

Growth & margins
Revenue growth (YoY)
10.6%

Higher than 55% of US stocks

Earnings growth (YoY)
29.3%

Higher than 66% of US stocks

Gross margin
78.7%

Higher than 90% of US stocks

Operating margin
19.5%

Higher than 79% of US stocks

Net margin
15.8%

Higher than 77% of US stocks

Returns & dividend
Return on equity
24.5%

Higher than 85% of US stocks

Return on assets
16.0%

Higher than 97% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.

Statistics

Key statistics

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Electromed, Inc. has a market value of $190.1M and an enterprise value of $174.3M.

  • Revenue in the twelve months to 30 June 2026: $73.8M. The latest quarter grew 11.6% year on year.

  • Net income over the same four quarters: $11.3M, a 15.3% net margin.

  • Diluted earnings per share, trailing twelve months: $1.31.

  • Free cash flow in the twelve months to 30 June 2026: $8.4M, after $1.3M of capital spending.

  • Electromed, Inc. spent $3.9M on share buybacks in the twelve months to 30 June 2026.

  • Shares outstanding: 8.4M.

  • Trailing P/E: 16.7×; forward P/E: 37.8× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Electromed, Inc. employs 195 people — $378K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 20 Nov 2026

Data provided by Twelve Data

Peers

ELMD and its peers

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
ELMDElectromed, Inc.$190.1M89
RXSTRxSight, Inc.$185.0M54
QSIQuantum-Si, Inc.$199.7M49
CLPTClearPoint Neuro, Inc.$221.5M29
OFIXOrthofix Medical, Inc.$240.4M60
SSIISS Innovations International, Inc.$245.9M11
LABStandard BioTools, Inc.$246.1M41

Take a look at ELMD’s peer groups, ranked by the model: healthcare stocks.

Look up any of the roughly 4,300 stocks we score.

The rank is the raw material. Whether the rules would actually own Electromed, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Questions about ELMD

What is the ELMD stock price forecast for 2026-2027?

The median 12-month analyst price target for Electromed, Inc. is $49, with estimates ranging from $47 to $50. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is ELMD stock a buy right now?

Of the 2 analysts covering Electromed, Inc., 2 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Electromed, Inc. 89 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank ELMD?

As at 21 Nov 2026, Electromed, Inc. ranks 89 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Quality (99 of 100).

Will ELMD stock go up?

No one can know that. What the data says: the median 12-month target from 2 analysts is $49, and Ticker Nerd's factor model ranks Electromed, Inc. 89 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the ELMD stock forecast for 2030?

No analyst covering Electromed, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ELMD are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $47 to $50 over the next 12 months.

How has ELMD stock performed over the past year?

Electromed, Inc. returned -8.4% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Electromed, Inc. do?

Electromed, Inc. is a medical device company focused on airway clearance therapy for patients with compromised pulmonary function. The company develops, manufactures, markets, and sells the SmartVest airway clearance system and related products that use high frequency chest wall oscillation (HFCWO) to help mobilize airway secretions.

Company

About Electromed, Inc.

Electromed, Inc. is a medical device company focused on airway clearance therapy for patients with compromised pulmonary function. The company develops, manufactures, markets, and sells the SmartVest airway clearance system and related products that use high frequency chest wall oscillation (HFCWO) to help mobilize airway secretions. Its portfolio includes home-use therapy systems as well as products designed for acute care settings, serving patients with conditions such as bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Electromed also offers connected therapy solutions that support communication between patients and physicians and help monitor treatment use. Headquartered in New Prague, Minnesota, Electromed plays a specialized role in respiratory care by providing noninvasive airway management tools used by clinicians, patients, and healthcare providers in the United States and selected international markets.

CEO Mr. James L. Cunniff · 195 employees · United States · https://smartvest.com